PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
NCT07598058 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2026-05-20
Summary
The design is a prospective, observational registry for subjects with CHE under the care of dermatology or other qualified healthcare provider. Longitudinal data are collected from both subjects and their treating provider during routine clinical encounters using a structured and standardized data collection method
Conditions
- Chronic Hand Eczema
Interventions
- OTHER
-
Observational (Non-Interventional) Registry
This is an observational (non-interventional) registry
Sponsors & Collaborators
-
CorEvitas
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-29
- Primary Completion
- 2099-12-31
- Completion
- 2099-12-31
More Related Trials
-
Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema
NCT05545215 ·Status: WITHDRAWN
-
Topical Ruxolitinib Evaluation in Chronic Hand Eczema
NCT05906628 ·Status: COMPLETED ·Phase: PHASE2
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis
NCT04553224 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
NCT05579899 ·Status: COMPLETED ·Phase: PHASE2
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING
-
An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
NCT03758716 ·Status: COMPLETED ·Phase: PHASE2
-
Dupilumab in Severe Chronic Hand Eczema
NCT04512339 ·Status: UNKNOWN ·Phase: PHASE2
-
Finding Patterns In Clinical Trial Experiences of Patients With Eczema
NCT05747378 ·Status: NOT_YET_RECRUITING
-
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
NCT05219864 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224 ·Status: COMPLETED ·Phase: PHASE4
-
Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective
NCT07323394 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
NCT04871711 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
NCT05233410 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT06397911 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema
NCT01882712 ·Status: WITHDRAWN ·Phase: PHASE3
-
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema
NCT04378569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
NCT00605878 ·Status: RECRUITING
-
Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema
NCT05355818 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)
NCT05682859 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa
NCT03827798 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Creation of a Shared Medical Decision-making Tool for Atopic Dermatitis
NCT05090982 ·Status: UNKNOWN
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3